Concepedia

Xiaoyang Li

XL

Statistics

Publications

60

Citations

1.9K

H-Index

26

Active since

2010

Affiliations

Shandong University(Current)

Ocean University of China

Medical University of South Carolina

Qingdao National Laboratory for Marine Science and Technology

Weifang Medical University

Xiaoyang Li is an author at Shandong University specializing in pharmacology, medicinal chemistry, and drug discovery.

ORCID

Publications per year

2010–2025

60

Publications

60

Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously

Jie Zang, Xuewu Liang, Yongxue Huang et al. · Journal of Medicinal Chemistry · 2018 · 104 citations · Full text

, , +16

Design, Synthesis, and Antitumor Evaluation of Novel Histone Deacetylase Inhibitors Equipped with a Phenylsulfonylfuroxan Module as a Nitric Oxide Donor

Wenwen Duan, Jin Li, Elizabeth S. Inks et al. · Journal of Medicinal Chemistry · 2015 · 88 citations · Full text

, , +12

Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological Malignancies

Xuewu Liang, Jie Zang, Xiaoyang Li et al. · Journal of Medicinal Chemistry · 2019 · 85 citations · Full text

, , +16

Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status

Xiaoyang Li, Yuri K. Peterson, Elizabeth S. Inks et al. · Journal of Medicinal Chemistry · 2018 · 83 citations · Full text

, , +14

Discovery of the First <i>N</i>-Hydroxycinnamamide-Based Histone Deacetylase 1/3 Dual Inhibitors with Potent Oral Antitumor Activity

Xiaoyang Li, Elizabeth S. Inks, Xiaoguang Li et al. · Journal of Medicinal Chemistry · 2014 · 76 citations · Full text

, , +10

1–5 of 60